Solid Biosciences Inc. SLDB
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +9.93%
- 1 year
- +15.03%
- Open
- 6.30
- Prev close
- 6.39
- Mkt cap
- 664.80M
- Vol
- 873.12K
- Avg vol
- 1.18M
- EPS
- -1.89
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.02
- High
- 6.42
- Forward P/E
- -5.46
- Beta
- 2.44
- Short ratio
- 17.18
- Inst. own
- 107.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 9.32
- 200-d avg
- 7.34
- 1y target
- 18.67
News
-
6 days ago benzinga.com
Solid Biosciences Says European Commission Grants Orphan Designation To SGT-212 For Treatment Of Friedreich’s Ataxia
- Obtaining Orphan designation from the European Commission reflects Solid’s commitment to the global development of SGT-212 for individuals living with Friedreich’s ataxia -- SGT-212 is a…
6 days ago globenewswire.com
Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich's Ataxia
- Obtaining Orphan designation from the European Commission reflects Solid's commitment to the global development of SGT-212 for individuals living with Friedreich's ataxia - - SGT-212 is a…
1 week ago defenseworld.net
Solid Biosciences (SLDB) Expected to Announce Quarterly Earnings on Monday
Solid Biosciences (NASDAQ: SLDB - Get Free Report) is projected to post its Q3 2026 results before the market opens on Monday, November 2nd. Analysts expect the company to announce earnings of…
-
2 weeks ago benzinga.com
UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20
UBS analyst Joon Lee initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $20.
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 7.8% to $1.52 during Friday's after-market session. The market value of their outstanding shares is at $3.3 million. 20/20 Biolabs…